RAY B — RaySearch Laboratories AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK8.50bn
- SEK8.55bn
- SEK1.19bn
Annual income statement for RaySearch Laboratories AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 652 | 642 | 844 | 1,022 | 1,192 |
| Cost of Revenue | |||||
| Gross Profit | 608 | 591 | 749 | 916 | 1,093 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 655 | 695 | 801 | 907 | 932 |
| Operating Profit | -3.47 | -53.3 | 42.7 | 115 | 260 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.48 | -58.7 | 32.4 | 110 | 263 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.08 | -47.3 | 23.8 | 81.6 | 204 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.08 | -47.3 | 23.8 | 81.6 | 204 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.08 | -47.3 | 23.8 | 81.6 | 204 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.265 | -1.38 | 0.694 | 2.38 | 5.94 |
| Dividends per Share |